tiprankstipranks
Cocrystal Pharma Inc (COCP)
NASDAQ:COCP
US Market

Cocrystal Pharma (COCP) Income Statement

Compare
993 Followers

Cocrystal Pharma Income Statement

Last quarter (Q3 2024), Cocrystal Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cocrystal Pharma's net income was $-4.94M. See Cocrystal Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 2.01M$ 6.56M
Gross Profit
$ -15.17M$ -241.60K$ -239.50K$ 1.78M$ 6.56M
Operating Expenses
$ 22.55M$ 18.14M$ 14.22M$ 11.60M$ 8.87M
Depreciation and Amortization
$ -1.39M$ 388.00K$ 382.00K$ 336.00K$ 254.00K
EBITDA
$ -19.37M$ -38.45M$ -13.80M$ -9.30M$ -47.90M
Operating Income
$ -18.56M$ -38.83M$ -14.22M$ -9.59M$ -48.41M
Other Income/Expenses
$ 575.00K$ -8.00K$ 36.00K$ -62.00K$ 237.00K
Pretax Income
$ -17.98M$ -38.84M$ -14.19M$ -9.65M$ -48.17M
Net Income
$ -17.98M$ -38.84M$ -14.19M$ -9.66M$ -48.19M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ -4.77$ -0.16$ -0.17$ -1.51
Diluted EPS
$ 0.00$ -4.77$ -0.16$ -0.17$ -1.51
Weighted Average Shares Outstanding
9.65M 8.14M 88.37M 55.22M 31.86M
Weighted Average Shares Outstanding (Diluted)
9.65M 8.14M 88.37M 55.22M 31.86M
Currency in USD

Cocrystal Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis